This brand name is authorized in Japan
The drug SULPREP contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Sodium sulfate
UNII 36KCS0R750 - SODIUM SULFATE ANHYDROUS
|
|
Sodium Sulfate Anhydrous is the anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions. |
|
2
Potassium sulfate
UNII 1K573LC5TV - POTASSIUM SULFATE
|
|
|
|
3
Magnesium sulfate
UNII SK47B8698T - MAGNESIUM SULFATE HEPTAHYDRATE
|
|
Magnesium sulfate is a saline purgative. It can be employed locally in various inflammatory conditions, due to its osmotic action. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 7990104S1029 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
